TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,141,000 | +17.2% | 161,950 | +0.5% | 0.34% | +12.0% |
| Q2 2016 | $1,827,000 | -35.9% | 161,069 | -34.1% | 0.30% | -34.4% |
| Q1 2016 | $2,849,000 | +5.1% | 244,350 | +6.0% | 0.46% | +17.8% |
| Q4 2015 | $2,711,000 | +52.6% | 230,550 | +48.0% | 0.39% | +61.9% |
| Q3 2015 | $1,777,000 | -54.9% | 155,746 | -28.7% | 0.24% | -43.6% |
| Q2 2015 | $3,944,000 | -7.7% | 218,400 | -1.6% | 0.42% | -2.3% |
| Q1 2015 | $4,274,000 | +25.7% | 222,050 | +14.3% | 0.43% | +24.7% |
| Q4 2014 | $3,401,000 | +17.0% | 194,250 | +22.1% | 0.35% | +18.0% |
| Q3 2014 | $2,908,000 | +255.5% | 159,150 | +348.3% | 0.30% | +268.8% |
| Q2 2014 | $818,000 | +85.5% | 35,500 | +95.1% | 0.08% | +77.8% |
| Q1 2014 | $441,000 | -3.7% | 18,200 | 0.0% | 0.04% | -10.0% |
| Q4 2013 | $458,000 | -13.7% | 18,200 | -25.4% | 0.05% | -15.3% |
| Q3 2013 | $531,000 | – | 24,400 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |